微泡
调解人
肺
医学
下调和上调
PI3K/AKT/mTOR通路
癌症研究
外体
心力衰竭
转录组
炎症
治疗效果
治疗方法
信号转导
药理学
细胞生物学
表型
肺动脉高压
化学
免疫学
病理
细胞
小RNA
循环系统
Wnt信号通路
作者
Halle J. Cantor,Dashuai Zhu,Zhenhua Li,Shiqi Hu,Kristen D. Popowski,Mengrui Liu,Junlang Li,Nate Mullens,Eric Thompson,Andrew Caddell,John D. Bonagura,Phuong‐Uyen Dinh,Ke Cheng
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-08-15
卷期号:20 (34): 23871-23883
标识
DOI:10.1021/acsnano.6c06951
摘要
Pulmonary hypertension-associated heart failure with preserved ejection fraction (PH-HFpEF) is a prevalent and lethal cardiopulmonary syndrome without effective disease-modifying therapy. We investigated the therapeutic potential of lung spheroid cell-derived exosomes (LSC-Exos) in a murine model of PH-HFpEF induced by high-fat diet feeding. The disease phenotype was validated by echocardiography and histologic assessment. Mice with established PH-HFpEF received daily nebulized LSC-Exo for 3 weeks. Treatment significantly improved right and left ventricular structural parameters, reduced regurgitation velocity, and attenuated pulmonary vascular wall thickening compared with untreated controls. Transcriptomic profiling revealed activation of PI3K-Akt signaling in the lung and suppression of downstream mTOR signaling in the heart following LSC-Exo therapy, with marked upregulation of miR-150-5p in cardiac tissue. To define the mechanistic contribution, diseased mice were treated with miR-150-5p-enriched exosomes or exosomes containing a miR-150-5p inhibitor. miR-150-5p-loaded exosomes recapitulated the majority of functional and structural improvements and modulated mTOR pathway activity, whereas inhibition of miR-150-5p attenuated therapeutic efficacy. No safety concerns were observed. These findings demonstrate that nebulized LSC-Exo therapy ameliorates cardiopulmonary remodeling in PH-HFpEF and identify exosomal miR-150-5p as a key mediator of therapeutic benefit via regulation of PI3K-Akt-mTOR signaling. This study supports the development of inhaled exosome-based therapies for cardiopulmonary vascular disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI